IP Group PLC (LSE:IPO) CEO Greg Smith talked with Proactive's Stephen about the company’s first half performance and outlook through to 2027. Smith said the group delivered £30.3 million of cash realisations in the first half, compared with just £3.3 million in the same period last year. He noted that this puts IP Group on track to meet its £50 million FY25 target and its longer-term goal of more than £250 million in cash exits by 2027. Smith highlighted portfolio progress, including the IPO of Hinge Health on the New York Stock Exchange and Oxford Nanopore beating guidance with its first half results. He said: “We made strong progress in the first half. We were pleased with some encouraging portfolio developments and also that this pipeline of significant milestones that are building through to the end of 2027.” He added that NAV per share has stabilised and ticked up post-period due to a recovery in public holdings. Smith also pointed to increased M&A interest across the portfolio and ongoing progress in securing new private scale-up capital mandates. Looking ahead, milestones include Istesso’s phase two trial, Oxford Nanopore’s full-year results, Hysata’s hydrogen rollout in Saudi Arabia, and developments at First Light Fusion. For more videos, visit Proactive’s YouTube channel. Don’t forget to give this video a like, subscribe to the channel, and enable notifications for future updates. #IPGroup #GregSmith #Investment #Portfolio #CashExits #OxfordNanopore #HingeHealth #Hydrogen #NuclearFusion #StockMarket #PrivateCapital #ProactiveInvestors